Chutes and ladders on the critical path:comparative effectiveness, product value, and the use of biomarkers in drug development

Clin Pharmacol Ther. 2009 Jul;86(1):12-4. doi: 10.1038/clpt.2009.33.
No abstract available

Publication types

  • News

MeSH terms

  • Animals
  • Biomarkers / analysis*
  • Critical Pathways / trends*
  • Drug Design
  • Drug Discovery / methods
  • Drug Discovery / trends*
  • Humans
  • United States
  • United States Food and Drug Administration / trends

Substances

  • Biomarkers